Clinical Trial Update: Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 23 mg donepezil to 10 mg in Japanese subjects with severe Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil hydrochloride 10 mg (donepezil hydrochloride)
• Donepezil hydrochloride 23 mg (donepezil hydrochloride)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Alzheimer's Type Dementia | Phase 3 | Status: COMPLETED